Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Correction: Corrigendum: Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming

The Original Article was published on 20 December 2009

Nat. Med. 16, 123–128 (2010); published online 20 December 2010; corrected after print 18 August 2016

In the version of this article initially published, the article did not mention some restrictions on the availability of reagents. Please note that the retroviral vectors containing BCL-6 and BCL-xL have been generated by a for-profit company, AIMM Therapeutics, which makes the plasmids available. Obtaining the plasmids requires an MTA (http://www.aimmtherapeutics.com/partnering/academic-collaboration/) that includes financial obligations.

Authors

Additional information

The online version of the original article can be found at 10.1038/nm.2071

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kwakkenbos, M., Diehl, S., Yasuda, E. et al. Correction: Corrigendum: Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming. Nat Med 22, 1502 (2016). https://doi.org/10.1038/nm1216-1502a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1216-1502a

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing